Virtual Bioequivalence: a myth or coming reality? [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2021-12-23 22:31 (275 d 02:15 ago) – Posting: # 22714
Views: 1,298

Hi Mittyri,

sorry for excavating such an old post.

» AFAIK regulatories are also interested and funding some of them.

See here and the back-story by authors of the FDA.*

» What do you think?

In my CRO I had the displeasure to deal with topical diclofenac. Low plasma concentrations doable by GC/MS with stable isotope IS but extremely variable. Really ugly profiles. Synovia was as close to a nightmare you can get. How to sample without contamination? We tried a lot of crazy stuff (cleaning the skin with acetone and isopropanol, skin stripping, …). Nothing worked. We ended up in patients scheduled for a total knee arthroplasty. Recruitment not easy “Why should I apply the cream daily under occlusion for three weeks when my knee is cut off anyway?” Turned out that >50% had a so-called ‘dry knee’, i.e., no synovia at all. Bad luck.
Given all that, I’m asking myself on which data the FDA’s model is based upon and how reliable they are. :confused:

Dif-tor heh smusma 🖖 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,385 posts in 4,684 threads, 1,594 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time: Sunday 01:46 CEST (Europe/Vienna)

You really don’t know what you don’t know until you write about it.
Then, everyone knows what you don’t know.    Rod Machado

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz